Efficacy and Safety of Dapagliflozin as Adjunct Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea. (2026). Academia Journal of Medicine, 9(2), 201-205. https://doi.org/10.48165/ajm.2026.9.02.34